Therapeutic Biomaterials for Chronic Osteomyelitis: Time-Space-Control Strategies for Infection Control and Bone

Jinqiu Tian1,2,3,4,5, Qi Meng1,2,3,4, Peixun Zhang1,2,3,4,6

  • 1Department of Trauma and Orthopaedics, Peking University People's Hospital, Beijing 100044, China.

Summary

New biomaterials for chronic osteomyelitis (infected bone defects) manage infection and promote bone regeneration. These materials use programmed timing, targeted delivery, and controlled release for better outcomes.